EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Toxic Epidermal Necrolysis complicating Infliximab therapy in Refractory Kawasaki disease

Abraham Kwak, Sung Ae Kim, Hee Joung Choi

Keimyung Medical Journal · 2020

DOI: 10.46308/kmj.2020.00094 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Keimyung Medical Journal, 2020. Verfasst von Abraham Kwak und 2 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe skin reactions complicating tumor necrosis factor-alpha (TNF-α) antagonist therapy were somewhat reported in adults.We report a case of 24-month-old boy with refractory Kawasaki disease who developed toxic epidermal necrolysis (TEN) after one dose of 5mg/kg infliximab.The patient responded to intravenous hydrocortisone and was able to discharge without any other serious complications.The clinicians should be aware of the potential for severe skin reactions from the use of TNF-α antagonists in children.

Zitieren

APA

Kwak, A., Kim, S. A., & Choi, H. J. (2020). Toxic Epidermal Necrolysis complicating Infliximab therapy in Refractory Kawasaki disease. Keimyung Medical Journal. https://doi.org/10.46308/kmj.2020.00094

Vancouver

Kwak A, Kim SA, Choi HJ. Toxic Epidermal Necrolysis complicating Infliximab therapy in Refractory Kawasaki disease. Keimyung Medical Journal. 2020. doi:10.46308/kmj.2020.00094

BibTeX
@article{Kwak2020,
  author = {Kwak, Abraham and Kim, Sung Ae and Choi, Hee Joung},
  title = {Toxic Epidermal Necrolysis complicating Infliximab therapy in Refractory Kawasaki disease},
  journal = {Keimyung Medical Journal},
  year = {2020},
  doi = {10.46308/kmj.2020.00094}
}
Kostenlos starten →